ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTMechanism of formation of 1,2,3,4-tetramethylnaphthalene from 2-butyne and triphenyltris(tetrahydrofuran) chromium(III)George M. Whitesides and William J. EhmannCite this: J. Am. Chem. Soc. 1970, 92, 19, 5625–5640Publication Date (Print):September 1, 1970Publication History Published online1 May 2002Published inissue 1 September 1970https://pubs.acs.org/doi/10.1021/ja00722a015https://doi.org/10.1021/ja00722a015research-articleACS PublicationsRequest reuse permissionsArticle Views460Altmetric-Citations56LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts
Background: Metabolites associated with betaine and choline metabolism and the gut-microbiota-dependent metabolite trimethylamine N-oxide (TMAO) have been linked to the risk of cardiovascular disease (CVD). However, the relationship between plasma concentrations of other gut microbiota-related metabolites and major CVD endpoints remains unclear. Objectives: To evaluate the association between gut microbiota-related metabolites and risk of incident CVD and the potential modifying effect of Mediterranean diet (MedDiet) interventions. Methods: We designed a case-cohort study nested within the PREDIMED trial. We used liquid chromatography–tandem mass spectrometry to measure plasma gut microbiota-related metabolites. A score including the sum of quartile values of 8 metabolites was constructed (TMAO, betaine, choline, phosphocholine, alphaglycerophosphocholine, proline, hydroxyproline, allantoin). The primary outcome was a composite of myocardial infarction, stroke, and cardiovascular death. Blood samples from a randomly selected PREDIMED sub-cohort (n=751) and all available incident CVD cases (n=229) after 4.8-y of follow-up were included in the analysis. We used weighted Cox regression models to estimate multivariable-adjusted hazard ratios (HR) and their 95% confidence intervals (CI). Models were adjusted for age, sex, BMI, family history of premature heart disease, and smoking, physical activity (metabolic equivalent tasks in min/d), hypertension, dyslipidemia, diabetes and was stratified by intervention group. Results: Baseline plasma concentrations of choline and hydroxyproline were associated with higher CVD risk independent of traditional risk factors, while no significant association between plasma concentrations of TMAO and CVD was found. The HRs comparing extreme quartiles (lowest quartile as the reference) were 1.72 (95% CI: 1.05, 2.81; P for trend=0.01) and 1.65 (95% CI: 1.03, 2.65; P for trend =0.04), respectively. The microbiota metabolite score was associated with a 2.13-fold higher risk of CVD across extreme quartiles (95% CI: 1.32, 3.43; P for trend <0.001) and a 1.99-fold higher risk of stroke (95% CI: 1.08, 3.65; P for trend=0.02). Baseline betaine/choline ratio was inversely associated with CVD. Compared to participants with a score below the median and randomized to the Mediterranean diet, the HR of developing CVD was 2.56 (95% CI: 1.59, 4.11) for participants with a gut microbiota score above the median and randomized to the control group. Conclusions: Plasma gut microbiota-related metabolites were associated with an increased risk of CVD in a Mediterranean population at high cardiovascular risk, independent of traditional CVD risk factors.
Letters16 July 2002Fruit and Vegetable Intake and Coronary Heart DiseaseKaumudi J. Joshipura, ScD, Frank B. Hu, MD, and Walter C. Willett, MDKaumudi J. Joshipura, ScDHarvard School of Public Health Boston, MA 02115 (Joshipura, Hu, Willett)Search for more papers by this author, Frank B. Hu, MDHarvard School of Public Health Boston, MA 02115 (Joshipura, Hu, Willett)Search for more papers by this author, and Walter C. Willett, MDHarvard School of Public Health Boston, MA 02115 (Joshipura, Hu, Willett)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-2-200207160-00021 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:The suggestion by Drs. Alves-Rodrigues and Thomas that the cardioprotective effect of green leafy vegetables may be related to high lutein levels is based on an animal study of lutein and arteriosclerosis (1) and a study among humans examining the relation between lutein and other antioxidants and coronary disease (2). In our study, we mentioned that antioxidant vitamins, folate, fiber, and such minerals as potassium may contribute to the apparent beneficial effects of fruits and vegetables, and we agree that lutein may also partly explain this benefit.Dr. Lindenauer and colleagues propose a new term, NNEB, as a ...References1. Dwyer JH, Navab M, Dwyer KM, Hassan K, Sun P, Shircore A, et al . Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study. Circulation. 2001;103:2922-7. [PMID: 11413081] CrossrefMedlineGoogle Scholar2. Howard AN, Williams NR, Palmer CR, Cambou JP, Evans AE, Foote JW, et al . Do hydroxy-carotenoids prevent coronary heart disease? A comparison between Belfast and Toulouse. Int J Vitam Nutr Res. 1996;66:113-8. [PMID: 8843985] MedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Harvard School of Public Health Boston, MA 02115 (Joshipura, Hu, Willett) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoThe Effect of Fruit and Vegetable Intake on Risk for Coronary Heart Disease Kaumudi J. Joshipura , Frank B. Hu , JoAnn E. Manson , Meir J. Stampfer , Eric B. Rimm , Frank E. Speizer , Graham Colditz , Alberto Ascherio , Bernard Rosner , Donna Spiegelman , and Walter C. Willett Fruit and Vegetable Intake and Coronary Heart Disease Alexandra Alves-Rodrigues and Boban Thomas Fruit and Vegetable Intake and Coronary Heart Disease Peter Lindenauer , Darius A. Rastegar , and Dorothea von Goeler Metrics 16 July 2002Volume 137, Issue 2Page: 144KeywordsAdverse reactionsAge distributionAntioxidantsCoronary heart diseaseFolic acidPotassiumRelative riskStable coronary artery diseaseVitamins ePublished: 16 July 2002 Issue Published: 16 July 2002 CopyrightCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...